PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study finds people on anti-obesity medications cut both weight and alcohol consumption

Researchers found moderate and heavy drinkers were most likely to reduce alcohol intake while on all types of anti-obesity medications

Study finds people on anti-obesity medications cut both weight and alcohol consumption
2024-12-04
(Press-News.org) DETROIT (Dec. 04, 2024)—Losing weight with anti-obesity medications (AOM) also resulted in decreased alcohol consumption for about half of the participants in a new study appearing in the current issue of JAMA Network Open.

The research, led by Lisa Miller-Matero, PhD, an associate scientist and Associate Director of Health Services Research at Henry Ford Health, adds to a growing body of research that suggests medications such as Ozempic or Wegovy could be adapted to treat substance use disorders.

“This was different from past research in that we included a variety of anti-obesity medications and looked at changes in alcohol use among people who reported casual consumption,” Miller-Matero said. “Other work primarily only included glucagon-like peptide-1 receptor agonists (GLP-1 RAs) among individuals with substance use disorders. We also compared GLP-1 RAs to metformin and bupropion/naltrexone, which are other anti-obesity medications.”

Researchers examined the drinking habits of 14,000 WeightWatchers members who began taking an AOM between January 2022 and August 2023 and refilled the same AOM between October 2023 and November 2023.

“What was exciting was that those who were drinking at higher, or even what is considered hazardous levels, had a greater likelihood of reducing alcohol use,” Miller-Matero said.

Prior to beginning their medication, participants were asked if their average weekly alcohol consumption was light (1-3 drinks per week for women and 1-6 drinks per week for men), moderate (4-6 per week for women and 7-14 per week for men), or heavy (7+ per week for women and 15+ per week for men.) Participants updated their consumption level again at the time of refill.

Among the approximately 7,500 participants who initially reported alcohol use, about 3,400 reported decreasing their category of alcohol use, with the biggest reduction reported by people originally in the moderate and heavy drinking categories. All types of AOMs were associated with reduced alcohol use.

“People on the WeightWatchers program who have used AOM have said: ‘My whole life I’ve been a social drinker, but now I’m not craving my glass of red wine,’ or ‘I’m drinking the same or less than before and am having the worst hangover of my life,’ therefore deterring their interest in alcohol,” said study senior author and WeightWatchers Chief Nutrition Officer Michelle Cardel, PhD, RD.

Miller-Matero says further research would help determine if the medications led to decreased alcohol use or if participants changed their drinking habits because they were consuming fewer calories and making healthier lifestyle choices. 

She said the findings also warrant further research into the use of anti-obesity medications for treating substance use.

###

 

END


[Attachments] See images for this press release:
Study finds people on anti-obesity medications cut both weight and alcohol consumption

ELSE PRESS RELEASES FROM THIS DATE:

ETSU secures $900k defense grant

2024-12-04
The U.S. Department of Defense has awarded the ETSU Research Corporation over $900,000 as part of the Defense Industrial Base Consortium, an investment that will help create new opportunities to foster regional innovation in sustainable industrial manufacturing in the Appalachian region. “Our goal is to enhance the prosperity of our region by connecting local innovation with opportunities in global emerging markets,” said Eric Jorgenson, vice president of evelopment for the ETSU Research Corporation. “This project is another key part of the foundation of a robust biomanufacturing ecosystem in ...

ETSU researcher earns grant to build flood dashboard using generative AI

2024-12-04
An East Tennessee State University researcher is developing a cutting-edge dashboard using generative artificial intelligence to assist in monitoring flooding in Central Appalachia.  The pilot project, titled "Leveraging Generative Artificial Intelligence (AI) for Automated Climate Resilience Dashboards: A Case Study on Flood Monitoring in Central Appalachia," has recently secured $20,000 in funding from the Earth Science Information Partners (ESIP) Lab.  Dr. Qian Huang from ETSU’s Center for Rural Health and Research, in collaboration with Dr. ...

AI-enabled analysis of images meant to catch one disease can reveal others

2024-12-04
With the help of an AI tool, computed tomography (CT) scans taken originally to look for tumors or bleeding or infections, also revealed calcium buildup in arteries, a sign of worsening cardiovascular disease.   This is the result of a new study led by researchers at NYU Langone Health and an example of a new trend in “opportunistic screening,” wherein radiologists repurpose existing medical images to diagnose illnesses beyond what the scan was originally designed to find. Presented at the annual Radiological Society of North America ...

Key objections to collecting immigration status data in national health surveys

Key objections to collecting immigration status data in national health surveys
2024-12-04
Nativity—characterized by place of birth, duration of residence in the host country, citizenship and immigration status—greatly influences the health of foreign-born individuals in the United States (U.S.). Despite this, many national health surveys omit questions about these dimensions of nativity, particularly immigration status. This omission limits the ability to assess health disparities across diverse immigrant subgroups and develop evidence-based policies and targeted interventions. To navigate this limitation, researchers rely on proxy measures or imputations ...

Clinical trial of device aims to induce ovulation in women with polycystic ovary syndrome

Clinical trial of device aims to induce ovulation in women with polycystic ovary syndrome
2024-12-04
Physicians at the University of Oklahoma Health Sciences in Oklahoma City are leading a national clinical trial to help women with polycystic ovary syndrome (PCOS)-related infertility who want to become pregnant. The trial, called REBALANCE, studies the safety and effectiveness of an investigational device developed by May Health that is designed to restore ovulation disrupted by PCOS. OU Health reproductive endocrinologist Karl Hansen, M.D., Ph.D., chair of the Department of Obstetrics and Gynecology at the OU College of Medicine, is leading the trial for ...

Natural ‘biopesticide’ against malaria mosquitoes successful in early field tests

2024-12-04
An experimental bacteria-derived biopesticide is highly effective in killing malaria-carrying mosquitoes, including those that have developed resistance to chemical pesticides, according to initial field tests led by researchers at the Johns Hopkins Bloomberg School of Public Health. The biopesticide is a powder made from the dead cells of a common soil-dwelling bacterial species. The researchers showed that the biopesticide efficiently kills both ordinary and chemical-pesticide-resistant mosquitoes when included in standard baits. ...

NSF-Piedmont Triad Regenerative Medicine Engine (PTRME) awards $2.5 million in grants to drive economic growth

2024-12-04
WINSTON-SALEM, N.C. – December 4, 2024 — The Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF), has announced a groundbreaking investment of $2.5 million in the region’s regenerative medicine industry through its inaugural Ecosystem Building Grant program. This milestone underscores PTRME’s leadership in regenerative medicine and commitment to positioning the Piedmont Triad as a global hub for innovation. Six innovative companies have been awarded grants ...

How plant enzymes can adapt to higher temperatures

2024-12-04
  Images EAST LANSING, Mich. – As global temperatures rise, it’s imperative that plants can adapt to new and changing conditions.  As global temperatures rise, it’s imperative that plants can adapt to new and changing conditions.  Michigan State University researchers from the Walker lab are looking at ways to give plants an assist. More specifically, their research aims to help plants adapt to changing temperatures by introducing engineered enzymes that will increase plants’ heat tolerance. “I would say that the main goal of our research is to prepare plants for elevated temperatures because, with climate change, ...

The Gerontological Society of America congratulates new 2024 Awardees

2024-12-04
The Gerontological Society of America (GSA) — the country’s largest interdisciplinary organization devoted to the field of aging — is proud to acknowledge the work of 34 outstanding individuals through its prestigious awards program. GSA salutes outstanding research, recognizes distinguished leadership in teaching and service, and fosters new ideas through a host of awards. Nominated by their peers, the recipients’ achievements serve as milestones in the history and development of gerontology. The awardees were honored at various ...

New facility for evaluating hydrogen-compatible materials now complete

New facility for evaluating hydrogen-compatible materials now complete
2024-12-04
1. NIMS has established and begun operating a new testing facility to evaluate the mechanical properties of materials exposed to low-temperature hydrogen environments. This facility can create hydrogen conditions across a broader range of temperatures and pressures than any other facility of its kind in the world. It is designed to assess the properties of materials when in contact with low-temperature gaseous or liquefied hydrogen, with the goal of developing cost-effective materials for hydrogen supply chains. This approach is expected to reduce the cost of producing and operating ...

LAST 30 PRESS RELEASES:

Tabbye M. Chavous named new Executive Director of the American Educational Research Association

Mindfulness and cognitive behavioral therapy improve chronic low back pain

Proteins shown to act as ‘guardians’ to keep cells’ energy making mitochondria safe

Letting your mind wander can sometimes improve learning

Exploring how people interact with virtual avatars

Hospital addiction consultation service increases medication treatment for opioid use disorder

Newly discovered PNS microglia found to regulate neuron size

Brain’s own repair mechanism: New neurons may reverse damage in Huntington’s disease

Neighborhood disadvantage, individual experiences of racism, and breast cancer survival

Cardioprotective glucose-lowering agents and dementia risk

Two-thirds of U.S. adolescent minors are impacted by state abortion restrictions

GLP-1RA and SGLT2i medications for type 2 diabetes and Alzheimer disease and related dementias

In the search for life on exoplanets, finding nothing is something too

Molecules that fight infection also act on the brain, inducing anxiety or sociability

Home care cooperatives may be key to addressing the critical shortage of caregivers for the elderly

Researchers have a proven prescription for reducing suicide rates

What if we find nothing in our search for life beyond Earth?

New findings on T cell exhaustion: The body prepares early for mild to severe disease

Howard University football team joins the Nation of Lifesavers

Korea University and Yonsei University's Colleges of Medicine promote a joint research project to train new Korean physician-scientists

Researchers discover way to predict treatment success for parasitic skin disease

Journal of Health Communication publishes inaugural Society for Health Communication special issue

‘Ugh, not that song!’ Background music impacts employees

New study finds that 90 percent of U.S. Christian leaders believe climate change is real

Study finds global downturn in bias against stigmatized groups

Cross-ideological acceptance of illiberal narratives and pro-China propaganda in Japan

AI tool can track effectiveness of multiple sclerosis treatments

The new season of The Last of Us has a spore-ting chance at realism

Alternative approach to Lyme disease vaccine development shows promise in pre-clinical models

Equitable access to digital technologies may help improve cardiovascular health

[Press-News.org] Study finds people on anti-obesity medications cut both weight and alcohol consumption
Researchers found moderate and heavy drinkers were most likely to reduce alcohol intake while on all types of anti-obesity medications